Vaccine

  Prevenar13®

  Pharmaceutical factory

  Number of serotypes

  Number of inoculation

        4 injections are recommended for babies from 6 weeks to 11 months        
        Only one injection for 2 years old or older

  Features

  Combination vaccine technology can promote immune memory, provide long-lasting protection
  Used by 83 national childhood vaccine programs

  Not suitable for

        Have had severe allergic reactions after receiving pneumococcal conjugate vaccine or the components of the vaccine (including antigen and protein carrier)
        Have had a severe allergic reaction after receiving a vaccine containing diphtheria vaccine components

  Precautions

  Before getting vaccinated, please check with your doctor for details due to your personal circumstances and vaccination records.

  Vaccine Name

VAXNEUVANCE™

  Pharmaceutical factory

  Number of serotypes

  Number of inoculations

People over 18 years old only need 1 dose (intramuscular injection)

  Features

        The 15-valent pneumococcal vaccine is effective against serotype 3 pneumococcus, has a stronger immune response.
        Prevent invasive pneumococcal infections such as pneumonia, acute otitis media, meningitis, sepsis, and others.
        It has been approved for use by the US FDA and the European Union, as well as in the United Kingdom, the United States, Australia, and Canada.

  Side Effects

        Pain, swelling, redness at the injection site
        Fatigue
        Muscle pain
        Headache
        Joint pain
  ** Side effects are mild and only last for a short period of time.

  Suitable for

18 years old or above.

  Not suitable for

        People who have had severe allergic responses to any component of the vaccination (including antigens and protein carriers).
        People who have had severe allergic reactions to diphtheria vaccine components.

  Precautions

        Can be given inactivated influenza vaccination at the same time.
        High-risk groups, such as the elderly, long-term patients, those who have had invasive pneumococcal illness, those with reduced immunity, and those with neurological problems, should be vaccinated with the 15-valent pneumococcal vaccine.